Rchr
J-GLOBAL ID:201801008334423564
Update date: Dec. 03, 2024
Yosuke Hirakawa
ヒラカワ ヨウスケ | Yosuke Hirakawa
Affiliation and department:
Research field (1):
Nephrology
Research theme for competitive and other funds (7):
- 2022 - 2025 Elucidation of mechanism how short chain fatty acids suppress kidney fibrosis.
- 2021 - 2023 Pathophysiological role of organelle contact site in tubular homeostasis
- 2019 - 2021 Examination of biological meaning of change in oxygen status and oxygen gradation in chronic kidney disease
- 2018 - 2021 Oxygen imaging of living tissues using confocal phosphorescence lifetime imaging microscope
- 2018 - 2021 Elucidation of metabolic reprogramming in the kidney and development of novel therapeutic approaches utilizing HIF against kidney disease
- 2018 - 2021 Molecular mechanism of organelle crosstalk on organ homeostasis in aging and disease
- 2017 - 2019 Elucidation of the mechanisms of renal hypoxia by phosphorescence lifetime measurement
Show all
Papers (28):
-
Yuka Sugawara, Yosuke Hirakawa, Masao Iwagami, Haruo Kuroki, Shuhei Mitani, Ataru Inagaki, Hiroki Ohashi, Mitsuru Kubota, Soichi Koike, Rie Wakimizu, et al. Correction: Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey. Journal of medical Internet research. 2024. 26. e68439
-
Yasuna Nakamura, Hirotaka Matsumoto, Chia-Hsien Wu, Daichi Fukaya, Rie Uni, Yosuke Hirakawa, Mikako Katagiri, Shintaro Yamada, Toshiyuki Ko, Seitaro Nomura, et al. Alpha 7 nicotinic acetylcholine receptors signaling boosts cell-cell interactions in macrophages effecting anti-inflammatory and organ protection. Communications biology. 2023. 6. 1. 666-666
-
Yuka Sugawara, Yosuke Hirakawa, Hajime Nagasu, Akira Narita, Akihiro Katayama, Jun Wada, Miho Shimizu, Takashi Wada, Hiromasa Kitamura, Toshiaki Nakano, et al. Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank. Journal of human genetics. 2022. 68. 2. 55-64
-
Yosuke Hirakawa, Kentaro Yoshioka, Kensuke Kojima, Yasuho Yamashita, Takuma Shibahara, Takehiko Wada, Masaomi Nangaku, Reiko Inagi. Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics. Scientific Reports. 2022. 12. 1. 16287-16287
-
Yuka Sugawara, Yosuke Hirakawa, Koki Mise, Kosuke Kashiwabara, Ko Hanai, Satoshi Yamaguchi, Akihiro Katayama, Yasuhiro Onishi, Yui Yoshida, Naoki Kashihara, et al. Analysis of inflammatory cytokines and estimated glomerular filtration rate decline in Japanese patients with diabetic kidney disease: a pilot study. Biomarkers in medicine. 2022. 16. 10. 759-770
more...
MISC (3):
-
木村 仁美, 大木 里花子, 平川 陽亮, 本田 謙次郎, 日向 宗利, 阿部 浩幸, 堂本 裕加子, 南学 正臣. 肺癌に対しPD-1阻害薬使用中に尿潜血および尿蛋白陽性を認めた一例. 日本腎臓学会誌. 2019. 61. 6. 732-732
-
Yosuke Hirakawa, Masaomi Nangaku. Targeting oxidative stress in diabetic kidney disease: a novel drug in an old pathway. Kidney International. 2018. 94. 6. 1038-1039
-
Yosuke Hirakawa, Tetsuhiro Tanaka, Masaomi Nangaku. Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease. JOURNAL OF DIABETES INVESTIGATION. 2017. 8. 3. 261-271
Return to Previous Page